Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2011 Jan 07;2861:243-51. doi: 10.1074/jbc.M110.139949.
Show Gene links
Show Anatomy links
Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.
Nagle MA
,
Truong DM
,
Dnyanmote AV
,
Ahn SY
,
Eraly SA
,
Wu W
,
Nigam SK
.
???displayArticle.abstract???
The organic anion transporters OAT1 (SLC22A6, originally identified by us as NKT) and OAT3 (SLC22A8) are critical for handling many toxins, metabolites, and drugs, including antivirals (Truong, D. M., Kaler, G., Khandelwal, A., Swaan, P. W., and Nigam, S. K. (2008) J. Biol. Chem. 283, 8654-8663). Although microinjected Xenopus oocytes and/or transfected cells indicate overlapping specificities, the individual contributions of these transporters in the three-dimensional context of the tissues in which they normally function remain unclear. Here, handling of HIV antivirals (stavudine, tenofovir, lamivudine, acyclovir, and zidovudine) was analyzed with three-dimensional ex vivo functional assays using knock-out tissue. To investigate the contribution of OAT1 and OAT3 in various nephron segments, the OAT-selective fluorescent tracer substrates 5-carboxyfluorescein and 6-carboxyfluorescein were used. Although OAT1 function (uptake in oat3(-/-) tissue) was confined to portions of the cortex, consistent with a proximal tubular localization, OAT3 function (uptake in oat1(-/-) tissue) was apparent throughout the cortex, indicating localization in the distal as well as proximalnephron. This functional localization indicates a complex three-dimensional context, which needs to be considered for metabolites, toxins, and drugs (e.g. antivirals) handled by both transporters. These results also raise the possibility of functional differences in the relative importance of OAT1 and OAT3 in antiviral handling in developing and mature tissue. Because the HIV antivirals are used in pregnant women, the results may also help in understanding how these drugs are handled by developing organs.
Ahn,
Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.
2009, Pubmed
Ahn,
Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.
2009,
Pubmed
Cihlar,
Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.
2001,
Pubmed
Eraly,
Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.
2006,
Pubmed
,
Xenbase
Eraly,
Novel aspects of renal organic anion transporters.
2003,
Pubmed
Hasegawa,
Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat.
2003,
Pubmed
Hussain,
Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.
2006,
Pubmed
Izzedine,
Antiviral drug-induced nephrotoxicity.
2005,
Pubmed
Kaler,
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
2007,
Pubmed
Kojima,
Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney.
2002,
Pubmed
Laitinen,
Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates.
1987,
Pubmed
Lopez-Nieto,
Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney.
1997,
Pubmed
,
Xenbase
Motohashi,
Gene expression levels and immunolocalization of organic ion transporters in the human kidney.
2002,
Pubmed
Nigam,
Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.
2007,
Pubmed
,
Xenbase
Pavlova,
Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct.
2000,
Pubmed
,
Xenbase
Ray,
Mechanism of active renal tubular efflux of tenofovir.
2006,
Pubmed
Servais,
Tubular transporters and clearance of adefovir.
2006,
Pubmed
Servais,
[Tubular transporters OAT1 and MRP2 and clearance of adefovir].
2005,
Pubmed
Sweet,
Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models.
2006,
Pubmed
Sweet,
Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient.
2003,
Pubmed
,
Xenbase
Sweet,
Organic anion transporter (Slc22a) family members as mediators of toxicity.
2005,
Pubmed
Sykes,
Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice.
2004,
Pubmed
Tahara,
Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney.
2005,
Pubmed
Takeda,
Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
2002,
Pubmed
Trifillis,
Isolation, culture and characterization of human renal proximal tubule and collecting duct cells.
1999,
Pubmed
Truong,
Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.
2008,
Pubmed
,
Xenbase
Uwai,
Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
2007,
Pubmed
Vallon,
Organic anion transporter 3 contributes to the regulation of blood pressure.
2008,
Pubmed
,
Xenbase
VanWert,
Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.
2010,
Pubmed
Wada,
Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs.
2000,
Pubmed
,
Xenbase
